Literature DB >> 7718601

Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin.

D Liu1, F Liu, Y K Song.   

Abstract

Liver uptake of liposomes containing phosphatidylserine was studied in a single pass liver perfusion system and found to be serum dependent. The effectiveness of serum in mediating liposome uptake by the liver depends on liposomes size. Large liposomes appeared to be opsonized more efficiently and, therefore, taken up more by the liver than the smaller ones. The effects of liposomes size on liver uptake did not occur in the absence of serum. Treatment of serum at 56 degrees C for 30 min abolished the serum activity, suggesting the involvement of complement components. Inhibition of the hemolytic activity of complement through the alternative pathway by PS-containing liposomes suggests that components in this pathway are responsible for liposome opsonization. Liposomes containing phosphatidic acid, phosphatidylglycerol, and dicetyl phosphate compete in different degrees for serum components which mediate the liver uptake of PS-containing liposomes. These results suggest that the opsonization of liposomes by serum opsonins are the determining factors for the recognition and clearance of liposomes by the RES. Complement components are most likely involved in this process. The results presented here are relevant to the use of liposomes as drug delivery vehicle in vivo and to the PS-mediated clearance of red blood cells from the blood circulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718601     DOI: 10.1016/0005-2736(95)00005-n

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Dysopsonin activity of serum DNA-binding proteins favorable for gene delivery.

Authors:  Feng Liu; Amber Frick; Xing Yuan; Leaf Huang
Journal:  J Pharmacol Exp Ther       Date:  2009-10-28       Impact factor: 4.030

Review 2.  Emission of membrane vesicles: roles in complement resistance, immunity and cancer.

Authors:  David Pilzer; Olivier Gasser; Oren Moskovich; Jurg A Schifferli; Zvi Fishelson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

3.  On-demand pH-sensitive surface charge-switchable polymeric micelles for targeting Pseudomonas aeruginosa biofilms development.

Authors:  Xiangjun Chen; Rong Guo; Changrong Wang; Keke Li; Xinyu Jiang; Huayu He; Wei Hong
Journal:  J Nanobiotechnology       Date:  2021-04-09       Impact factor: 10.435

4.  Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.

Authors:  A Adedoyin; J F Bernardo; C E Swenson; L E Bolsack; G Horwith; S DeWit; E Kelly; J Klasterksy; J P Sculier; D DeValeriola; E Anaissie; G Lopez-Berestein; A Llanos-Cuentas; A Boyle; R A Branch
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

Review 5.  Polymersome carriers: from self-assembly to siRNA and protein therapeutics.

Authors:  David A Christian; Shenshen Cai; Diana M Bowen; Younghoon Kim; J David Pajerowski; Dennis E Discher
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

6.  Emerging Applications of Polymersomes in Delivery: from Molecular Dynamics to Shrinkage of Tumors.

Authors:  Dennis E Discher; Vanessa Ortiz; Goundla Srinivas; Michael L Klein; Younghoon Kim; David Christian; Shenshen Cai; Peter Photos; Fariyal Ahmed
Journal:  Prog Polym Sci       Date:  2007-08-01       Impact factor: 29.190

Review 7.  The physiology of cardiovascular disease and innovative liposomal platforms for therapy.

Authors:  Guillermo U Ruiz-Esparza; Jose H Flores-Arredondo; Victor Segura-Ibarra; Guillermo Torre-Amione; Mauro Ferrari; Elvin Blanco; Rita E Serda
Journal:  Int J Nanomedicine       Date:  2013-02-09

8.  Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s.

Authors:  Birgit Romberg; Christien Oussoren; Cor J Snel; Wim E Hennink; Gert Storm
Journal:  Pharm Res       Date:  2007-08-03       Impact factor: 4.200

9.  Complement-dependent clearance of apoptotic cells by human macrophages.

Authors:  D Mevorach; J O Mascarenhas; D Gershov; K B Elkon
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

Review 10.  Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications.

Authors:  Yin Zhao; Wei Wei; Ming-Lin Liu
Journal:  J Autoimmun       Date:  2020-09-04       Impact factor: 14.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.